# Pancreatic Perfusion Using Secretin and MRI

> **NCT02458118** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Nottingham** · enrollment: 15 (estimated)

## Conditions studied

- Chronic Pancreatitis

## Interventions

- **DRUG:** Secretin

## Key facts

- **NCT ID:** NCT02458118
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2016-04
- **Final completion:** 2016-06
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2016-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02458118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02458118, "Pancreatic Perfusion Using Secretin and MRI". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02458118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*